Want to see TSE:ASEP full AI Analyst Report?

ASEP Medical Holdings Inc (ASEP) Price & Analysis

7 Followers

ASEP Stock Chart & Stats

C$0.31

-C$0.03(-33.33%)

At close: Jan 07 4:00 PM EST

C$0.31

-C$0.03(-33.33%)

Day’s Range― - ―

52-Week RangeC$0.09 - C$0.50

Previous CloseN/A

Volume0.00

Average Volume (3M)0.00

Market Cap

C$2.22M

Enterprise ValueC$1.40M

Total Cash (Recent Filing)C$510.63K

Total Debt (Recent Filing)C$220.00K

Price to Earnings (P/E)―

Beta-1.62

Next Earnings

Aug 10, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares Outstanding15,873,520

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-0.52

Price to Book (P/B)10.12

Price to Sales (P/S)6035.17

P/FCF Ratio-46.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Financial LeverageLow financial leverage suggests ASEP has a conservative capital structure, which may provide stability and reduce financial risk in the long term.

Innovative Product DevelopmentA strong focus on R&D can lead to innovative products that address unmet medical needs, potentially driving future growth and competitive advantage.

Strategic PartnershipsStrategic partnerships can enhance ASEP's market presence and product portfolio, facilitating revenue growth and long-term business sustainability.

Bears Say

Negative Cash FlowNegative cash flow indicates ASEP struggles to generate sufficient cash from its core operations, potentially impacting its ability to fund growth and meet obligations.

Persistent LossesOngoing losses highlight ASEP's struggle with profitability, which could threaten its financial health and ability to invest in future growth.

Negative Profit MarginsNegative profit margins suggest ASEP is not efficiently converting revenues into profits, indicating operational inefficiencies that may hinder long-term success.

ASEP Medical Holdings Inc News

Asep Medical to Retire Over $1 Million in Debt Through Share Issuance

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has issued an announcement. Asep Medical Holdings Inc. plans to settle...

5M ago

Asep Medical Adds Industry Veteran O’Shaughnessy to Board to Drive Sepsis and Anti-Biofilm Strategy

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has issued an announcement. Asep Medical Holdings Inc., a Canadian biotech...

5M ago

Asep Medical Launches C$1.17 Million LIFE Financing to Fund R&D and Debt Repayment

An update from ASEP Medical Holdings Inc ( ($TSE:ASEP) ) is now available. Asep Medical Holdings Inc. plans...

5M ago

Asep Medical Names Dr. Richard Heinzl Interim CEO Amid Push to Advance Diagnostic Technologies

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) just unveiled an update. Asep Medical Holdings Inc. has appointed board...

5M ago

Asep Medical Reshapes Leadership to Sharpen Scientific Focus and Drive Next Growth Phase

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) just unveiled an announcement. Asep Medical Holdings Inc. has announced a...

5M ago

Asep Medical Resumes Trading After Revocation of Cease Trade Order

An update from ASEP Medical Holdings Inc ( ($TSE:ASEP) ) is now available. Asep Medical Holdings Inc. announced...

8M ago

Asep Medical Holdings Updates Year-End Management Discussion and Analysis

An update from ASEP Medical Holdings Inc ( ($TSE:ASEP) ) is now available. Asep Medical Holdings Inc. has...

8M ago

Asep Medical Licenses Anti-Biofilm Technology to Bondent for Oral Rinse in China

The latest announcement is out from ASEP Medical Holdings Inc ( ($TSE:ASEP) ). Asep Medical Holdings Inc. has...

9M ago

Asep Medical Secures Investment to Boost Sepsis Diagnostic Development

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has provided an update. Asep Medical Holdings Inc. announced that its...

11M ago

Asep Medical’s Sepset ER Test Validated for Sepsis Detection

ASEP Medical Holdings Inc ( ($TSE:ASEP) ) has issued an update. Asep Medical Holdings Inc. announced that its...

1y ago

ASEP FAQ

What was ASEP Medical Holdings Inc’s price range in the past 12 months?

ASEP Medical Holdings Inc lowest stock price was C$0.09 and its highest was C$0.50 in the past 12 months.

What is ASEP Medical Holdings Inc’s market cap?

ASEP Medical Holdings Inc’s market cap is C$2.22M.

When is ASEP Medical Holdings Inc’s upcoming earnings report date?

ASEP Medical Holdings Inc’s upcoming earnings report date is Aug 10, 2026 which is in 6 days.

How were ASEP Medical Holdings Inc’s earnings last quarter?

Currently, no data Available

Is ASEP Medical Holdings Inc overvalued?

According to Wall Street analysts ASEP Medical Holdings Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does ASEP Medical Holdings Inc pay dividends?

ASEP Medical Holdings Inc does not currently pay dividends.

What is ASEP Medical Holdings Inc’s EPS estimate?

ASEP Medical Holdings Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ASEP Medical Holdings Inc have?

ASEP Medical Holdings Inc has 15,873,520 shares outstanding.

What happened to ASEP Medical Holdings Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of ASEP Medical Holdings Inc?

Currently, no hedge funds are holding shares in TSE:ASEP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

ASEP Medical Holdings Inc

Asep Medical Holdings Inc. is dedicated to advancing medical solutions, primarily through its subsidiary, ASEP Medical Inc. The company's core focus involves pioneering an early diagnostic method for Sepsis, as well as developing innovative peptide-based therapeutic treatments applicable to a variety of medical conditions. Established in 2020, this Vancouver, Canada-based firm was formerly known as Trenchant Life Sciences Investment Corp. before adopting its present identity.